Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites.
Open Access
- 1 January 1998
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 101 (1) , 235-242
- https://doi.org/10.1172/jci626
Abstract
Normalization of the increased vascular nitric oxide (NO) generation with low doses of NG-nitro-L-arginine methyl ester (L-NAME) corrects the hemodynamic abnormalities of cirrhotic rats with ascites. We have undertaken this study to investigate the effect of the normalization of vascular NO production, as estimated by aortic cyclic guanosine monophosphate (cGMP) concentration and endothelial nitric oxide synthase (eNOS) protein expression in the aorta and mesenteric artery, on sodium and water excretion. Rats with carbon tetrachloride-induced cirrhosis and ascites were investigated using balance studies. The cirrhotic rats were separated into two groups, one receiving 0.5 mg/kg per day of L-NAME (CIR-NAME) during 7 d, whereas the other group (CIR) was administrated the same volume of vehicle. Two other groups of rats were used as controls, one group treated with L-NAME and another group receiving the same volume of vehicle. Sodium and water excretion was measured on days 0 and 7. On day 8, blood samples were collected for electrolyte and hormone measurements, and aorta and mesenteric arteries were harvested for cGMP determination and nitric oxide synthase (NOS) immunoblotting. Aortic cGMP and eNOS protein expression in the aorta and mesenteric artery were increased in CIR as compared with CIR-NAME. Both cirrhotic groups had a similar decrease in sodium excretion on day 0 (0.7 versus 0.6 mmol per day, NS) and a positive sodium balance (+0.9 versus +1.2 mmol per day, NS). On day 7, CIR-NAME rats had an increase in sodium excretion as compared with the CIR rats (sodium excretion: 2.4 versus 0.7 mmol per day, P < 0.001) and a negative sodium balance (-0.5 versus +0.8 mmol per day, P < 0.001). The excretion of a water load was also increased after L-NAME administration (from 28+/-5% to 65+/-7, P < 0.05). Plasma renin activity, aldosterone and arginine vasopressin were also significantly decreased in the CIR-NAME, as compared with the CIR rats. The results thus indicate that normalization of aortic cGMP and eNOS protein expression in vascular tissue is associated with increased sodium and water excretion in cirrhotic rats with ascites.Keywords
This publication has 49 references indexed in Scilit:
- Hyperdynamic circulation in patients with cirrhosis: direct measurement of nitric oxide levels in hepatic and portal veinsJournal of Hepatology, 1997
- Role of endothelium in the abnormal response of mesenteric vessels in rats with portal hypertension and liver cirrhosisGastroenterology, 1996
- Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascitesHepatology, 1996
- Cellular mechanism of angiotensin II-induced atrial natriuretic peptide release in rat right atrial tissueLife Sciences, 1996
- Cirrhosis with ascites: Increased atrial natriuretic peptide messenger RNA expression in rat ventricleGastroenterology, 1995
- Pathogenesis of arterial hypotension in cirrhotic rats with ascites: Role of endogenous nitric oxideHepatology, 1992
- Carbon tetrachloride induced cirrhosis in rats: A useful tool for investigating the pathogenesis of ascites in chronic liver diseaseJournal of Gastroenterology and Hepatology, 1992
- Inhibition of nitric oxide synthesis in septic shock: how much is beneficial?The Lancet, 1991
- Proximal nephron and renal effects of DuP 753, a nonpeptide angiotensin II receptor antagonistKidney International, 1990
- Beneficial effect of 8-ornithin vasopressin on renal dysfunction in decompensated cirrhosis.Gut, 1989